Sign in to edit your profile (add interests, overview, photo, etc.)

    An, Dahlia

    TitleResearch Assoc Sr
    SchoolLawrence Berkeley National Lab
    DepartmentChemical Sciences
    Address1 Cyclotron Road
    Berkeley CA 94720
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Captain I, Deblonde GJ, Rupert PB, An D, Illy MC, Rostan E, Ralston CY, Strong RK, Abergel RJ. Engineered Recognition of Tetravalent Zirconium and Thorium by Chelator-Protein Systems: Toward Flexible Radiotherapy and Imaging Platforms. Inorg Chem. 2016 Nov 1. PMID: 27802058.
        View in: PubMed
      2. An D, Kullgren B, Jarvis EE, Abergel RJ. From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents. Chem Biol Interact. 2016 Mar 31. PMID: 27038878.
        View in: PubMed
      3. Kamada K, Namikawa T, Senatore S, Matthews C, Lenne PF, Maury O, Andraud C, Ponce-Vargas M, Le Guennic B, Jacquemin D, Agbo P, An D, Gauny SS, Liu X, Abergel RJ, Fages F, D'Aléo A. Boron Difluoride Curcuminoid Fluorophores with Enhanced Two-Photon Excited Fluorescence Emission and Versatile Living-Cell Imaging Properties. Chemistry. 2016 Apr 4; 22(15):5219-32. PMID: 26919627.
        View in: PubMed
      4. Allred BE, Rupert PB, Gauny SS, An D, Ralston CY, Sturzbecher-Hoehne M, Strong RK, Abergel RJ. Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides. Proc Natl Acad Sci U S A. 2015 Aug 18; 112(33):10342-7. PMID: 26240330.
        View in: PubMed
      5. Choi TA, Endsley AN, Bunin DI, Colas C, An D, Morales-Rivera JA, Villalobos JA, Shinn WM, Dabbs JE, Chang PY, Abergel RJ. Biodistribution of the Multidentate Hydroxypyridinonate Ligand [(14) C]-3,4,3-LI(1,2-HOPO), a Potent Actinide Decorporation Agent. Drug Dev Res. 2015 May; 76(3):107-22. PMID: 25857483.
        View in: PubMed
      6. An D, Villalobos JA, Morales-Rivera JA, Rosen CJ, Bjornstad KA, Gauny SS, Choi TA, Sturzbecher-Hoehne M, Abergel RJ. (238)Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice. Int J Radiat Biol. 2014 Nov; 90(11):1055-61. PMID: 24937372.
        View in: PubMed
      7. Sturzbecher-Hoehne M, Kullgren B, Jarvis EE, An D, Abergel RJ. Highly luminescent and stable hydroxypyridinonate complexes: a step towards new curium decontamination strategies. Chemistry. 2014 Aug 4; 20(32):9962-8. PMID: 25043376.
        View in: PubMed
      8. Kullgren B, Jarvis EE, An D, Abergel RJ. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions. Toxicol Mech Methods. 2013 Jan; 23(1):18-26. PMID: 22957518.
        View in: PubMed

      A U.S. Department of Energy National Laboratory Managed by the University of California

      This site is running Profiles RNS version v2.10.1-414-g6fb82b0a.